Letters To The Editor

In reply: Eruptive xanthoma

Author and Disclosure Information

 

In Reply: In our article , we described a patient who presented with markedly elevated triglyceride and hemoglobin A 1c. Hypertriglyceridemia might be secondary to underlying diseases, including uncontrolled diabetes, or to inherited lipid disorders. In the optimal situation, our patient would have benefited most not only from strict control of his triglycerides and diabetes, but also from testing for inherited lipid disorders. Although insulin was initiated, he refused fibrates and genetic counseling, and he refused to be reassessed later. After 1 and 3 months, his clinical and laboratory findings had improved dramatically, deterring us from further intervention.

Recommended Reading

Avoiding Diabetes in Patients With Hepatitis C
Type 2 Diabetes ICYMI
ADA: DPP4 inhibitors and cardiovascular outcomes: connecting the dots
Type 2 Diabetes ICYMI
Lixisenatide news is good, but search for the ‘holy grail’ continues
Type 2 Diabetes ICYMI
July 2015: Click for Credit
Type 2 Diabetes ICYMI
Angina drug ranolazine lowers glucose in type 2 diabetes
Type 2 Diabetes ICYMI
Angina Drug Ranolazine Lowers Glucose in Type 2 Diabetes
Type 2 Diabetes ICYMI
Study quantifies risks linked to cardiac multimorbidity
Type 2 Diabetes ICYMI
Liraglutide shrank epicardial fat 42% in type 2 diabetes
Type 2 Diabetes ICYMI
CABG costs more in patients with diabetes
Type 2 Diabetes ICYMI
Poor glycemic control upped chances of coronary events after CABG
Type 2 Diabetes ICYMI

Related Articles

  • Article

    Eruptive xanthoma

    Endocrine Society guidelines recommend fibrates as the first-line therapy for elevated triglycerides.